To validate the expression profile of MCRGs in clinical patients, we examined the expression of oncogenes (SYCE2, SERPINE1, TRIP6, LIMK1, and EEPD1) by RT-qPCR in 8 pairs of clinical samples from CRC patients. Here, SYCE2 is linked to colorectal carcinoma.